Location History:
- Toyonaka, JP (1986 - 1987)
- Ibaraki, JP (1987)
Company Filing History:
Years Active: 1986-1987
Title: Yasuhiro Katsuragi: Innovator in Pharmaceutical Compositions
Introduction
Yasuhiro Katsuragi is a prominent inventor based in Toyonaka, Japan, renowned for his contributions to pharmaceutical compositions. With a total of four patents to his name, Katsuragi's innovative work focuses on enhancing the efficacy of treatments for infectious diseases and malignant tumors.
Latest Patents
Among his latest patents, one notable invention is a composition for activating the function of phagocytes. This pharmaceutical or veterinary composition includes a specific tocopheryl glycoside as an active ingredient, demonstrating promise in the treatment of infectious diseases and malignant tumors. Another significant patent is for a pharmaceutical composition containing interferon in a stable state. This composition is designed to treat viral diseases and is available in various forms, including pasta, gargle, gel, ointment, suppository, and spray. It comprises an effective amount of human interferon along with stabilizers, and has a pH range of about 3 to 6. Optional components can include an anionic surfactant and albumin for improved stability.
Career Highlights
Throughout his career, Yasuhiro Katsuragi has made significant strides within the pharmaceutical industry. Notable companies where he contributed include Sunstar and 501 Sunstar, where his innovative ideas flourished.
Collaborations
Katsuragi has collaborated with esteemed colleagues, including Yasuo Sakano and Kenji Aimoto, further enhancing his research and development efforts. These collaborations have played a crucial role in the advancement of his inventions.
Conclusion
Yasuhiro Katsuragi continues to be a driving force in the field of pharmaceutical innovation. His dedication to improving health outcomes through his inventions makes him a notable inventor in the industry, and his patents pave the way for future advancements in medical treatments.